Literature DB >> 3260340

Hypergammaglobulinemia associated with human immunodeficiency virus infection.

C B Reimer1, C M Black, R C Holman, T W Wells, R M Ramirez, J A Sa-Ferreira, J K Nicholson, J S McDougal.   

Abstract

The serum concentrations of 11 Ig isotypes (IgG, IgG1, IgG2, IgG3, IgG4, IgA, IgA1, IgA2, IgM, IgD, and IgE) were measured in four relatively small groups of homosexual (or bisexual) males. All these patients were seropositive for HIV. Two of the groups (nonprogressors) were clinically stable for approximately 2 years and were characterized either as asymptomatic or with PGL. The third group (progressors) developed AIDS 2-38 months after blood specimens were taken. The fourth group had AIDS. A fifth group of anti-HIV-seronegative heterosexual males completed the study. The geometric mean IgA serum concentration was more markedly elevated over normal control sera than any of the other study groups and was the only Ig isotype that was significantly higher in the progressor than in the nonprogressor group. The geometric IgG1 serum concentration was significantly higher in asymptomatic nonprogressors, PGL-nonprogressors, progressors, and AIDS patient groups than that in HIV-seronegative normals. In contrast, the geometric mean IgG2 serum concentration is depressed in all the anti-HIV-seropositive patients (but not significantly with the AIDS group). Multivariate analysis showed the Ig-isotype assays to have much less predictive power for progression to AIDS than the T-helper cell assays.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260340

Source DB:  PubMed          Journal:  Monogr Allergy        ISSN: 0077-0760


  10 in total

1.  Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV).

Authors:  F Müller; S S Frøland; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals.

Authors:  Xueling Wu; Susan Jackson
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

3.  Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

Authors:  Andrew Rosa Borges; Lindsay Wieczorek; Benitra Johnson; Alan J Benesi; Bruce K Brown; Richard D Kensinger; Fred C Krebs; Brian Wigdahl; Robert Blumenthal; Anu Puri; Francine E McCutchan; Deborah L Birx; Victoria R Polonis; Cara-Lynne Schengrund
Journal:  Virology       Date:  2010-09-28       Impact factor: 3.616

4.  Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.

Authors:  Clarisa M Buckner; Susan Moir; Jason Ho; Wei Wang; Jacqueline G Posada; Lela Kardava; Emily K Funk; Amy K Nelson; Yuxing Li; Tae-Wook Chun; Anthony S Fauci
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

Review 5.  Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Authors:  Margaret E Ackerman; Galit Alter
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

6.  Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells.

Authors:  Geneviève Martin; Jocelyn Roy; Corinne Barat; Michel Ouellet; Caroline Gilbert; Michel J Tremblay
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

7.  Enumeration of human peripheral blood lymphocytes secreting immunoglobulins of major classes and subclasses in healthy children and adults.

Authors:  F K Lee; A J Nahmias; T Spira; H Keyserling; S Lowery; C Reimer; C Black; B Stoll; C Czerkinsky
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

8.  Deficit of IgG2 in HIV-positive pregnant women is responsible of inadequate IgG2 levels in their HIV-uninfected children in Malawi.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Giuseppe Liotta; Mauro Andreotti; Sandro Mancinelli; Robert Mphwere; Enok Bokola; Roberta Amici; Maria Cristina Marazzi; Leonardo Palombi; Francesca Lucaroni; Marina Giuliano
Journal:  Med Microbiol Immunol       Date:  2018-02-27       Impact factor: 3.402

9.  Transforming growth factor-beta and suppression of humoral immune responses in HIV infection.

Authors:  J Kekow; W Wachsman; J A McCutchan; W L Gross; M Zachariah; D A Carson; M Lotz
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Placental transfer of anti-group B Streptococcus immunoglobulin G antibody subclasses from HIV-infected and uninfected women to their uninfected infants.

Authors:  Kirsty Le Doare; Stephen Taylor; Lauren Allen; Andrew Gorringe; Paul T Heath; Beate Kampmann; Anneke C Hesseling; Christine E Jones
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.